Drug resistance in tuberculosis in Delhi: A 2 year profile (2001-2002)

Journal of Communicable Diseases

Volumn 35, Issue 2, 2003, Pages 74-81

  Negi, Sanjay Singh ^a   Gupta, Sunil ^a   Lal, Shiv ^a  

^a NATIONAL INSTITUTE OF COMMUNICABLE DISEASES   (India)

Author keywords

Acquired drug resistance; Ethambutol (EMB); Initial drug resistance; Isoniazid (INH); Multidrug resistance (MDR); Rifampicin (RMP); Streptomycin (SM); Thiacetazone (THIA)

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; THIOACETAZONE;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; COMMUNICABLE DISEASE; DRUG SENSITIVITY; HUMAN; INDIA; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; STATISTICAL SIGNIFICANCE; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; DRUG RESISTANCE, MULTIPLE; ETHAMBUTOL; HUMANS; INDIA; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN; STREPTOMYCIN; THIOACETAZONE; TUBERCULOSIS, PULMONARY;

EID: 4444351994     PISSN: 00195138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Bloom BR and Murray CJ. Tuberculosis: Commentary on a reemergent killer. Science 1992; 257: 1055
2. Jagota P. Revised National Tuberculosis Control programme-a success story. Ind J Tub 2002; 49: 69.
3. Pathania V, Almedia J and Kochi. TB patients and private for profit health care providers in India. WHO\TB\1999; 223.
4. Trivedi SS and Desai SC. Primary antituberculosis drug resistance and acquired rifampicin resistance in Gujarat-India. Tubercle 1988; 69: 37.
5. Jain NK, Chopra KK and Prasad G. Initial and acquired INH and rifampicin resistant to Mycobacterium tuberculosis and its implications for treatment. Indian J Tub 1992; 39: 180.
6. Snider DE, Cauthen GM and Lawrence SF. Drug resistant tuberculosis. Am Rev Respir Dis 1991; 144: 732.
7. Chawla PK, Klapper PJ and Kamholz SL. Drug resistant tuberculosis in an urban population including patient at risk for human immunodeficiency virus infection. Am Rev Respir Dis 1992; 146: 280.
8. Gangadharam PRJ. Drug resistance in mycobacteria. Baton Range FL, CRC, 1984; 53.
9. Canetti G, Froman S and Grosset J. et al. Mycobacteria: laboratory methods for testing drug sensitivity and resistance. WHO Bull 1963; 29: 565.
10. Krishnaswamy KV and Rahim MA. Primary drug resistance in pulmonary tuberculosis. Ind J Chest Dis 1976; 28: 233.
11. Paramasivan CN, Chandrasekaran V, Santha T, Sudarsanam NM and Prabhakar R. Bacteriological investigation for short course chemotherapy under the tuberculosis programme in two districts in India. Tub Lung Dis 1993; 74: 23.
12. Chandrasekaran S, Chauhan MM, Rajalakshmi R, Chaudhari K and Mahadev B. Initial drug resistance to antituberculosis drugs in patients attending an urban district tuberculosis center. Ind J Tub 1990; 37: 215.
13. Gupta PR, Singhal B, Sharma TN and Gupta RB. Prevalence of initial drug resistance in tuberculosis patients attending a chest hospital. Ind J Med Res 1993; 97: 102.
14. Parmasivan CN, Bhaskaran K, Venkataraman P, Chaandrasekaran V, Narayanan PR. Surveillance of drug resistance in turbulencies in the state of Tamil Nadu. Ind J Tub 2000; 47: 27.
15. Malhotra B, Pathak S, and Vyas L. et al. Drug susceptibility profiles of Mycobacterium tuberculosis isolates at Jaipur. Ind J Med Res Microbiol 2002; 20: 76.
16. Datta M, Radhamani MP, and Selvaraj R. et al. Critical assessment of smear-positive pulmonary tuberculosis patients after chemotherapy under district tuberculosis programme. Tub Lung Dis 1993; 74: 180.
17. Chowgule RV and Deodhar L Pattern of secondary acquired drug resistance to antituberculosis drug in Mumbai, India, 1991-1995. Ind J Chest Dis Allied Sci 1998; 40: 23.
18. Parmasivan CN, Bhaskaran K, Venkataraman P, Chandrasekaran V and Narayanan PR. Surveillance of drug resistance in tuberculosis in the state of Tamil Nadu. Ind J Tub 2000; 47: 27.